Pune, March 27, 2023 (GLOBE NEWSWIRE) -- Maximize Market research, a global Healthcare market research firm, has published competitive intelligence market research report on “Breast Cancer Drug Market“. The Breast Cancer Drug market size was valued at USD 32.5 Bn in 2021. The total Breast Cancer Drug Market revenue is expected to grow at a CAGR of 14.8 percent from 2022 to 2029, reaching USD 98.04 Bn during the forecast period.
Breast Cancer Drug Market Overview
Breast Cancer is most commonly diagnosed tumor among women globally. Breast cancer is the world's second biggest cause of death. Increasing prevalence of breast cancer for effective treatment is expected to influence the Breast Cancer Market growth. Huge investment in Research and Development activities for promoting drug development and clinical trial procedures is fuelling the market growth.
| Market Size in 2021 | USD 32.5 Bn |
| Market Size in 2029 | USD 98.04 Bn |
| CAGR | 14.8 percent (2022-2029) |
| Forecast Period | 2022-2029 |
| Base Year | 2021 |
| Number of Pages | 265 |
| No. of Tables | 129 |
| No. of Charts and Figures | 121 |
| Segment Covered | By Breast Cancer Type, Cancer Stages, Drug Type, Drug Mechanism, Types Of Drug Treatment, Route of Administration, Distribution Channel |
| Regional Scope | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Report Coverage | Market Share, Size & Forecast by Revenue | 2022−2029, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis. |
Request For Free Sample Report: https://www.maximizemarketresearch.com/request-sample/169949
Breast Cancer Drug Market Scope and Research Methodology
The report on Breast Cancer Drug Market provides an in-depth analysis of the industry. Key highlights of the report include the market size and the growth rate. Insights of the report include the major applications and drivers of the market, challenges to growth and opportunities for Breast Cancer Drug market growth. The report covers a thorough regional analysis of the Breast Cancer Drug industry at local, regional and global level. Segments covered in the report are by Breast Cancer Type, Cancer Stages, Drug Type, Drug Mechanism, Types of Drug Treatment, Route of Administration, and Distribution Channel.
The report covers the Breast Cancer Drug market strategies followed by major players and provide their analysis on the basis of growth in the last few years in the industry which helps investors and major companies decide their investments and to make data-driven decisions. Primary and secondary research methods were used to collect the data from the Breast Cancer Drug market. Data from supply and demand side were collected to estimate the Breast Cancer Drug market size. Key players are identified through secondary research. Secondary research was used to collect information for the extensive, market-oriented, and commercial analysis of the Breast Cancer Drug Market.
High prevalence of Breast Cancer among the population across world is expected to fuel the Breast Cancer Drug Market growth
Large patient population demanding accurate and efficient treatment options is expected to influence the Breast Cancer Drug Market growth. There is high demand for preventive care and early treatment, which led many individuals to undergo cancer screening tests. Launch of new technological advancement in drugs for the treatment of breast cancer is expected to drive the Breast Cancer Drug Market growth. Preference for personalized medicines is expected to present a lucrative opportunity for the Breast Cancer Drug Market growth. Personalized medicines industry is expected to reach USD 112 Bn by 2029.
Adverse effect of drugs on the patient’s body while treatment is expected to restrain the Breast Cancer Drug Market growth. Chemotherapy medications harm human health such as hair loss, mouth sores, weight fluctuations, nausea, and vomiting.
North America region is expected to fuel the Breast Cancer Drug Market growth
North America region dominated the Breast Cancer Market in terms of revenue in 2021 and is expected to grow at high growth rate over the forecast period. There is a large presence of major market players in the region. Prevalence of breast cancer in the region, with increasing demand for preventative drugs, and R & D activities for clinical trial of drugs are expected to drive the Breast Cancer Drug market growth.
The United States is expected to present lucrative opportunities for the Breast Cancer Drug Market growth. The region has generated the highest market share of 48 percent in terms of revenue in 2021.
Get Customization on this Report for Specific Research Solutions: https://www.maximizemarketresearch.com/request-customization/169949
Breast Cancer Drug Market Segmentation
Based on Types of Drug Treatment, Chemotherapy for Breast Cancer segment to dominate the Brest Cancer Drug Market over the forecast period
Chemotherapy for Breast Cancer segment dominated the market with largest share in terms of revenue in 2021. The Breast Cancer Drug Market is expected to continue the dominance with highest growth rate over the forecast period. It is the most common therapy used to treat triple-negative breast cancer. Increase in new product launch is expected to increase the Breast Cancer Drug Market Growth.
Based on Distribution Channel, Hospital Pharmacies segment to dominate the Breast Cancer Drug Market over the forecast period
Large number of patients depending on filling up of oral prescription drugs is expected to contribute to the Hospital Pharmacies segment growth.
By Breast Cancer Type:
- Ductal Carcinoma In Situ (DCIS)
- Invasive Ductal Carcinoma (IDC)
- Tubular Carcinoma of the Breast
- Medullary Carcinoma of the Breast
- Mucinous Carcinoma of the Breast
- Papillary Carcinoma of the Breast
- Male Breast Cancer
- Others
By Cancer Stages:
- T: Primary Tumor Size
- N: Lymph Node Involvement
- M: Cancer spread beyond the breast and lymph nodes
By Drug Type:
- Herceptin Hylecta
- Atezolizumab
- Talazoparib
- Ribociclib
- Abemaciclib
- Neratinib
- Palbociclib
- Others
By Drug Mechanism:
- HER2 Inhibitors
- Mitotic Inhibitors
- Anti-metabolites
- Aromatase Inhibitors
- CDK 4/6 Inhibitors
- Hormonal Receptor
By Types of Drug Treatment:
- Chemotherapy for Breast Cancer
- Hormone Therapy for Breast Cancer
- Targeted Drug Therapy for Breast Cancer
- Immunotherapy for Breast Cancer
By Route of Administration:
- Oral
- Injection
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/169949
Breast Cancer Drug Market Key Players Include:
- JOHNSON & JOHNSON (United States)
- Merck & Co (United States)
- Bristol-Myers Squibb (United States)
- Eli Lilly (United States)
- Celgene (New Jersey)
- Gilead Sciences (California)
- Allergen (California)
- Bayer (New Jersey)
- Astellas Pharma (Illinois)
- PFIZER (New York)
- Amgen (California)
- ABBVIE (Illinois)
- AstraZeneca (United Kingdom)
- GlaxoSmithKline (United Kingdom)
- Sanofi (France)
- UCB (Belgium)
- Les Laboratoires Servier (France)
- Roche (Switzerland)
- Novartis (Switzerland)
- BeiGene (Beijing)
- Incyte (Switzerland)
- Bausch Health Company (Canada)
- Fresenius (Germany)
- Novo Nordisk (Denmark)
- Shire (England)
- Grifols (Spain)
- Dr.Reddy (India)
- Daiichi Sankyo (Japan)
- Takeda (Japan)
- CSL (Australia)
- Otsuka Holdings (Japan)
- Chugai Pharmaceutical (Japan)
- Sumitomo Dainippon Pharma (Japan)
- Sun Pharmaceuticals Industries (India)
- Eisai (Japan)
JOHNSON & JOHNSON:
At Johnson & Johnson, they believe in good health of vibrant lives, thriving communities and forward progress. They are uniquely positioned to help improve personal health by delivering products that are rooted in science and endorsed by professionals. They have breakthrough scientific innovation to address unmet needs. The total annual revenue of company in 2022 was USD 94.943 Bn.
Merck & Co:
They are following the science to tackle world’s greatest health threats. Their clinical trials help find new treatments to help save and improve lives. They bring creative minds together to invent important medicines and vaccines. The total annual revenue of the company in 2022 was USD 59.3 Bn.
Key questions answered in the Breast Cancer Drug Market are:
- What is Breast Cancer Drug?
- What was the Breast Cancer Drug market size in 2021?
- What is the expected Breast Cancer Drug market size by 2029?
- What is the growth rate of the Breast Cancer Drug Market?
- Which are the factors expected to drive the Breast Cancer Drug market growth?
- Which factors are expected to restrain the Breast Cancer Drug market growth?
- Which segment dominated the Breast Cancer Drug market growth?
- What is the demand pattern for the Breast Cancer Drug market?
- Which region held the largest share in the Breast Cancer Drug market?
- Who are the key players in the Breast Cancer Drug market?
Get a Sample Copy of the Report : https://www.maximizemarketresearch.com/request-sample/169949
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2021)
- Past Pricing and price curve by region (2018 to 2021)
- Market Size, Share, Size & Forecast by different segment | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
- Market Segmentation – A detailed analysis by Breast Cancer Type, Cancer Stages, Drug Type, Drug Mechanism, Types Of Drug Treatment, Route of Administration, Distribution Channel
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Lung Cancer Screening Market: The total market size was valued at USD 2.18 Bn in 2021 and the total revenue is expected to grow at a CAGR of 8.32 percent from 2022 to 2029, reaching USD 4.13 Bn. Increasing R&D activities and product approvals is expected to influence the market growth.
Cancer Supportive Care Drugs Market: The total market size was valued at USD 10.92 Bn in 2021 at CAGR 5.7 percent and is expected to reach USD 17.02 Bn by 2029. Large number of adverse effects associated with cancer therapy, and increasing penetration of biosimilars is expected to influence the market growth.
Sarcoma Drugs Market: The total market size was valued at USD 759.2 Mn in 2021 and the total Sarcoma Drugs revenue is expected to grow by 23 percent from 2022 to 2029, reaching USD 1405.3 Mn. Growing incidence and prevalence of various types of cancers is expected to drive the market growth.
Immunology Drug Market: The total market size was valued at USD 92.68 Bn in 2021 and the total revenue is expected to grow at CAGR 8.1 percent through 2022 to 2029, reaching USD 172.82 Bn. Increasing various type of environmental factors including exposure to the toxic chemical is expected to drive the market growth.
Antiviral Drug Market: The total market size was valued at USD 64.39 Bn in 2021 and the total revenue is expected to grow at CAGR 4.2 percent through 2021 to 2029, reaching USD 89.49 Bn. Increasing prevalence of viral infections such as HIV, influenza, herpes, hepatitis, and other viral infections is expected to drive the market growth.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
